Immunotherapy, particularly ICIs, shows potential in treating certain STS subtypes, but efficacy varies and requires further investigation. Blood-based biomarkers, including neutrophil-to-lymphocyte ...
A recent trial presented an unexpected survival benefit for patients with high-risk soft tissue sarcoma who were on anthracycline-based neoadjuvant chemotherapy. Despite the technically negative ...
Vitamin D Deficiency Impairs Rituximab-Mediated Cellular Cytotoxicity and Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With but Not Without Rituximab Review of the prospective ...
Due to a lack of suitable studies, it is unclear whether patients with soft tissue sarcoma can benefit from autologous haematopoietic stem cell transplantation. Owing to the current gaps in knowledge, ...
Soft-tissue sarcoma (STS) is a rare disease that encompasses over 50 separate histological subtypes with varying sensitivity to systemic treatment Chemotherapy has been based on historical experience ...
Dynatronics Corporation announced that net income for the fiscal second quarter was down from the prior year period and introduced a new handheld electrode for soft-tissue therapy. “Due to uncertainty ...
Hosted on MSN
Soft Tissue Sarcoma: Causes, Symptoms and Treatments
Causes of Soft Tissue Sarcoma:The exact soft tissue sarcoma causes remain unclear, but several risk factors have been identified. These include a family history of inherited conditions such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback